Experts Skeptical As Russia’s COVID-19 Vaccine Outshines Pfizer Results

Efficacy Of 92% Claimed For Sputnik V

Russian claims of superior efficacy two days after Pfizer’s good news look politically motivated

Russia Sputnik Vaccine
Russia claimed the world's first COVID-19 vaccine approval in August - and has now claimed superiority to Pfizer's candidate in interim results.

More from Clinical Trials

More from R&D